Birdwatch Note
2023-02-28 01:27:01 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
"Although raw numbers were not presented in the paper the primary outcome differed by a total of just 20 cases between the treatment and control arms: In a study population of over 300,000 individuals there were 1106 symptomatic seropositives in control and 1086 in treatment." https://trialsjournal.biomedcentral.com/articles/10.1186/s13063-022-06704-z
Written by DA1CE6B5155F4FB13AE546958A7A0E460080B24340952155667FC47868ECE445
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1630000813450964993
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1630379007525920768
- noteId - 1630379007525920768
- participantId - DA1CE6B5155F4FB13AE546958A7A0E460080B24340952155667FC47868ECE445
- noteAuthorParticipantId -
- createdAtMillis - 1677547621031
- tweetId - 1630000813450964993
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 0
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- "Although raw numbers were not presented in the paper the primary outcome differed by a total of just 20 cases between the treatment and control arms: In a study population of over 300,000 individuals there were 1106 symptomatic seropositives in control and 1086 in treatment." https://trialsjournal.biomedcentral.com/articles/10.1186/s13063-022-06704-z
Note Status History
| createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
| 2023-02-28 01:27:01 UTC (1677547621031) |
1969-12-31 23:59:59 UTC (-1) |
2023-03-07 02:11:29 UTC (1678155089929) |
NEEDS_MORE_RATINGS | 1969-12-31 23:59:59 UTC (-1) |
Note Ratings
| rated at | rated by | |
| 2023-02-27 20:56:27 -0600 | 0AD9DC83091CCD638FEA2C5486DBAFFEB24C6D23C499F284C80BF60D3E54AE95 | Rating Details |
| 2023-02-28 18:09:45 -0600 | 0D476FB8162A0B894FADC488B9348FFA9313C980B22262F5BC4C4D30F5AA0BC0 | Rating Details |
| 2023-02-28 03:22:54 -0600 | 251AC165CB5ED83F4E14DDCD4B8093F263B74DF7BAD439D346626E95C30F3D4B | Rating Details |
| 2023-02-28 04:13:46 -0600 | 2B4B21671FBEF5C1BC6D6267837E7235ACC20986970C9A5B56CA86ADB2FB9E0B | Rating Details |
| 2023-02-28 02:55:42 -0600 | 2EBF26F60F3A7E9005DA089FC61E341428510E1CA440226B1C2CB0CD463748D6 | Rating Details |
| 2023-02-28 06:27:35 -0600 | 351C24F925739877A4D8AB18810FE42663D18EA7B0316DDAD6CE5513BD192816 | Rating Details |
| 2023-02-28 18:39:44 -0600 | 386CBA97FA2604BB5BFB206F36315DCC46BA97CE97CBFEFADC262EEDFBA93D1A | Rating Details |
| 2023-02-27 22:15:13 -0600 | 43C0C6E62BBB03EF795C48F090C5C67A52516FE15C8B571592C9BE8300DFD93E | Rating Details |
| 2023-02-28 02:11:12 -0600 | 4CCDD7AF764C9F6485C92DCB3D585A1937F7D26C5DE4747A537177F84A5C4395 | Rating Details |
| 2023-02-28 13:28:12 -0600 | 4E9ED2B88C89FCE13BE6D40C0615D510C7FAA4CF0923DBA3E8945CCB20A8E82E | Rating Details |
| 2023-02-27 19:55:23 -0600 | 4EFE941EEE443BB7CC6EE07F79670B2B14FD67012FCF750117419F5C64A9B567 | Rating Details |
| 2023-02-28 13:14:10 -0600 | 5F70567B58C0AD8B38AE064172F7358F84DA61D6E07139A62A16F57A4EBA2A57 | Rating Details |
| 2023-02-27 19:36:20 -0600 | 65109B6CBF27037A850CDCFD1D120D151FC44AA7666864FA5B40F5BF0CC87BD4 | Rating Details |
| 2023-02-27 19:41:26 -0600 | 7D54F22CE3B73B5239B8B38D0C45AFA9777CC59E2DB07203A1CF2C8759343BE5 | Rating Details |
| 2023-02-28 07:46:42 -0600 | 95B846B262167637B241A05FA2D748F27F442B3EE06DE5D0CBFD3F97E0DFD75E | Rating Details |
| 2023-02-28 09:15:30 -0600 | 9B559AA6B09B99FEA94168488D83194CC3D7D90C12457AC7E7F46D04005D29B2 | Rating Details |
| 2023-03-05 11:10:15 -0600 | A861844748BF0CA637470389721039969DDDD03266E73A16BE6D5E42C702DDA8 | Rating Details |
| 2023-02-27 19:29:14 -0600 | AA10D49699E6620C77603388B971BA6E8F4081D4FF8595A608AA94ACAC6F160E | Rating Details |
| 2023-02-28 02:50:57 -0600 | B289B7B9A72A2B21A5016714B5CFECC892B67D4EF528AD49D229201250F7B83A | Rating Details |
| 2023-02-28 13:28:12 -0600 | Rating Details | |
| 2023-02-28 18:09:45 -0600 | Rating Details | |
| 2023-02-27 20:56:27 -0600 | Rating Details | |
| 2023-02-28 09:15:30 -0600 | Rating Details | |
| 2023-02-27 22:15:13 -0600 | Rating Details | |
| 2023-02-27 19:55:23 -0600 | Rating Details | |
| 2023-02-28 18:39:44 -0600 | Rating Details | |
| 2023-02-28 04:13:46 -0600 | Rating Details | |
| 2023-02-28 06:27:35 -0600 | Rating Details | |
| 2023-02-28 02:11:12 -0600 | Rating Details | |
| 2023-03-05 11:10:15 -0600 | Rating Details | |
| 2023-02-27 19:36:20 -0600 | Rating Details | |
| 2023-02-28 13:14:10 -0600 | Rating Details | |
| 2023-02-27 19:29:14 -0600 | Rating Details | |
| 2023-02-28 02:55:42 -0600 | Rating Details | |
| 2023-02-28 03:22:54 -0600 | Rating Details | |
| 2023-02-28 02:50:57 -0600 | Rating Details | |
| 2023-02-27 19:41:26 -0600 | Rating Details | |
| 2023-02-28 07:46:42 -0600 | Rating Details |